Immunotherapy & Oncology
Cancer treatment has moved from poisoning dividing cells towards directing the immune system at the tumour, and towards drugs that carry their payload only to cancerous tissue. It absorbs more drug development spending than any other area.
388 stocks
| # | Name | Holding | Trade Value |
Theme Stocks |
% of Portfolio | Status | |
|---|---|---|---|---|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
| $159B | +$2.04B | 196 | 2.57% | Increased |
|
| 2 |
BlackRock
New York
| $141B | +$1.56B | 224 | 2.69% | Increased |
|
| 3 |
State Street
Boston,
Massachusetts
| $79.1B | -$500M | 188 | 2.96% | Reduced |
|
| 4 |
Geode Capital Management
Boston,
Massachusetts
| $37.8B | +$561M | 234 | 2.65% | Increased |
|
| 5 |
JP Morgan Chase
New York
| $36.1B | +$1.18B | 188 | 2.36% | Increased |
|
| 6 |
Morgan Stanley
New York
| $33.8B | +$145M | 242 | 2.2% | Increased |
|
| 7 |
Fidelity Investments
Boston,
Massachusetts
| $32.8B | -$2.74B | 169 | 1.85% | Reduced |
|
| 8 |
Wellington Management Group
Boston,
Massachusetts
| $24.2B | -$250M | 72 | 4.39% | Reduced |
|
| 9 |
Charles Schwab
San Francisco,
California
| $22.8B | +$1.37B | 127 | 3.94% | Increased |
|
| 10 |
Bank of America
Charlotte,
North Carolina
| $22B | -$632M | 250 | 1.61% | Reduced |
|
| 11 |
Norges Bank
Oslo,
Norway
| $21.5B | +$164M | 38 | 2.69% | Increased |
|
| 12 |
Northern Trust
Chicago,
Illinois
| $19.4B | -$383M | 187 | 2.67% | Reduced |
|
| 13 |
Capital International Investors
Los Angeles,
California
| $16.9B | -$1.31B | 13 | 2.91% | Reduced |
|
| 14 |
T. Rowe Price Associates
Baltimore,
Maryland
| $16.4B | -$1.49B | 110 | 1.86% | Reduced |
|
| 15 |
UBS AM
Chicago,
Illinois
| $14.8B | +$1.78B | 67 | 2.99% | Increased |
|
| 16 |
Capital World Investors
Los Angeles,
California
| $14.3B | -$2.53B | 16 | 2.07% | Reduced |
|
| 17 |
Franklin Resources
San Mateo,
California
| $14.2B | +$99.1M | 74 | 3.76% | Increased |
|
| 18 |
Bank of New York Mellon
New York
| $13.6B | -$902M | 120 | 2.56% | Reduced |
|
| 19 |
Goldman Sachs
New York
| $12.7B | +$251M | 156 | 1.72% | Increased |
|
| 20 |
Dimensional Fund Advisors
Austin,
Texas
| $12.3B | +$600M | 111 | 2.84% | Increased |
|
| 21 |
Invesco
Atlanta,
Georgia
| $11.6B | -$351M | 109 | 1.97% | Reduced |
|
| 22 |
Legal & General Group
London,
United Kingdom
| $11.3B | +$56.5M | 110 | 2.79% | Increased |
|
| 23 |
Dodge & Cox
San Francisco,
California
| $11.2B | +$357M | 13 | 6.32% | Increased |
|
| 24 |
Primecap Management
Pasadena,
California
| $11.2B | -$346M | 19 | 8.85% | Reduced |
|
| 25 |
Capital Research Global Investors
Los Angeles,
California
| $10.8B | -$3.87B | 11 | 2.15% | Reduced |
|